1. Home
  2. IFBD vs ALZN Comparison

IFBD vs ALZN Comparison

Compare IFBD & ALZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Infobird Co. Ltd

IFBD

Infobird Co. Ltd

HOLD

Current Price

$0.98

Market Cap

8.4M

Sector

Technology

ML Signal

HOLD

Logo Alzamend Neuro Inc.

ALZN

Alzamend Neuro Inc.

HOLD

Current Price

$2.17

Market Cap

9.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IFBD
ALZN
Founded
2001
2016
Country
China
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Medicinal Chemicals and Botanical Products
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.4M
9.0M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
IFBD
ALZN
Price
$0.98
$2.17
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$42.00
AVG Volume (30 Days)
19.5K
97.7K
Earning Date
01-01-0001
12-09-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$4,861,442.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
1520.48
N/A
52 Week Low
$0.88
$1.88
52 Week High
$2.70
$12.06

Technical Indicators

Market Signals
Indicator
IFBD
ALZN
Relative Strength Index (RSI) 46.29 46.65
Support Level $0.92 $2.09
Resistance Level $1.05 $2.27
Average True Range (ATR) 0.07 0.14
MACD 0.00 0.01
Stochastic Oscillator 32.20 61.70

Price Performance

Historical Comparison
IFBD
ALZN

About IFBD Infobird Co. Ltd

Infobird Co Ltd is engaged in developing and providing customer engagement cloud-based services. It software-as-a-service provider of AI-powered, or artificial intelligence-enabled, customer engagement solutions in China. It provides holistic software solutions to help corporate clients proactively deliver and manage end-to-end customer engagement activities at all stages of the sales process, including pre-sales and sales activities, and post-sales customer support. It also offers AI-powered cloud-based sales force management software, including intelligent quality inspection and intelligent training software to help clients monitor, benchmark, and improve the performance of agents.

About ALZN Alzamend Neuro Inc.

Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's.

Share on Social Networks: